about
Decreased ex vivo production of interferon-gamma is associated with severity and poor prognosis in patients with lupus.Renal outcome after kidney-transplantation in Korean patients with lupus nephritis.Birmingham vasculitis activity score of more than 9.5 at diagnosis is an independent predictor of refractory disease in granulomatosis with polyangiitis.Malignancies in Korean patients with immunoglobulin G4-related disease.Birmingham vasculitis activity score at diagnosis is a significant predictor of relapse of polyarteritis nodosa.The antibody atliximab attenuates collagen-induced arthritis by neutralizing AIMP1, an inflammatory cytokine that enhances osteoclastogenesis.Chest and renal involvements, Birmingham vascular activity score more than 13.5 and five factor score (1996) more than 1 at diagnosis are significant predictors of relapse of microscopic polyangiitis.Fever as an initial manifestation of spondyloarthritis: A retrospective study.Application of the 2016 EULAR/ACR/PRINTO Classification Criteria for Macrophage Activation Syndrome in Patients with Adult-onset Still Disease.In-hospital mortality in febrile lupus patients based on 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome.The clinical utility of splenic fluorodeoxyglucose uptake for diagnosis and prognosis in patients with macrophage activation syndrome.Evaluation of Spleen Glucose Metabolism Using 18F-FDG PET/CT in Patients with Febrile Autoimmune Disease.Clinical significance of delta neutrophil index in the differential diagnosis between septic arthritis and acute gout attack within 24 hours after hospitalization.Renal outcome of kidney-transplantation in Korean recipients with ANCA-associated vasculitis.Reclassification of polyarteritis nodosa based on the 1990 ACR criteria using the 2007 EMA algorithm modified by the 2012 CHCC definitions.Echocardiographic features in patients with ANCA-associated vasculitis within 3 months before and after diagnosis.Increased serum interleukin-32 levels in patients with Behçet's disease.Rheumatoid factor false positivity in patients with ANCA-associated vasculitis not having medical conditions producing rheumatoid factor.The utility of the ACR/EULAR 2017 provisional classification criteria for granulomatosis with polyangiitis in Korean patients with antineutrophil cytoplasmic antibody-associated vasculitis.The initial predictors of death in 153 patients with ANCA-associated vasculitis in a single Korean centre.Cancer development in Korean patients with ANCA-associated vasculitis: a single centre study.Serum aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1), a novel disease activity predictive biomarker of systemic lupus erythematosus.Red Blood Cell Distribution Width Can Predict Vasculitis Activity and Poor Prognosis in Granulomatosis with Polyangiitis.Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis.Defective autophagy activity and its association with spinal damage in patients with ankylosing spondylitis.Birmingham vasculitis activity and chest manifestation at diagnosis can predict hospitalised infection in ANCA-associated vasculitis.Safety of Tocilizumab in Rheumatoid Arthritis Patients with Resolved Hepatitis B Virus Infection: Data from Real-World Experience.Mean platelet volume can estimate the current vasculitis activity of microscopic polyangiitis.Five factor score of more than 1 is associated with relapse during the first 2 year-follow up in patients with eosinophilic granulomatosis with polyangiitis.HBsAg-negative and anti-HBc-positive in eosinophilic granulomatosis with polyangiitis: a retrospective pilot study.The prevalence and the clinical relevance of anti-Ro52 in Korean patients with primary Sjögren's syndromeRisk factors associated with inadequate control of disease activity in elderly patients with rheumatoid arthritis: Results from a nationwide KOrean College of Rheumatology BIOlogics (KOBIO) registrySubclinical but significant liver fibrosis in patients with ANCA-associated vasculitisC-Reactive Protein to Serum Albumin Ratio Is an Independent Predictor of All-Cause Mortality in Patients with ANCA-Associated VasculitisAntineutrophil Cytoplasmic Antibody-Associated Vasculitis in Korea: A Narrative ReviewComparison of Radiological and Histological Findings of Lung Parenchyma in Patients with Antineutrophil Cytoplasmic Antibody-Associated VasculitisSerum Aminoacyl-tRNA Synthetase-Interacting Multifunctional Protein-1 Can Predict Severe Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Pilot Monocentric Study.2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease by Wallace et alAnti-Smith antibody is associated with disease activity in patients with new-onset systemic lupus erythematosusPrognostic nutritional index is correlated with disease activity in patients with systemic lupus erythematosus
P50
Q38607989-BC2DC988-E883-4D4F-97DC-772C410182C6Q38629081-C79AE331-74FB-4299-87AA-F867D073CA5CQ38647220-FAD9BA39-277C-4E36-9BD2-4FDB9BA5355DQ38764097-2E23D910-181A-43BB-929B-6D1E283E668DQ38877243-B9A6BB29-3B9A-47F0-A458-7F30D444AFD5Q38916969-E044C534-8361-4DEE-92FB-3730C3CD6D97Q38992569-A34CF132-7FB6-4476-8CA5-003B04A92FA8Q40038890-2A63499B-C35F-4050-B3E1-5BD6EC669781Q40060914-4838C655-5E27-474A-9C09-972654834F0DQ40066456-7AC2DA5B-FD9B-4324-BAE9-7C7C2718FA61Q40082328-7274AE57-8FB1-4112-9CB7-1EC1CDA42DF3Q40086863-38BAB448-F61E-4EA3-BDE9-0A15C63AE7A3Q40119003-1D4B9F0F-D02A-4BCF-B168-1C94F125097DQ47398094-D9A43CD0-CA1D-4CAD-A22A-444DD3C891B0Q47660856-4784F23B-BA72-4A82-8F7B-5E728B05AD99Q47843978-DD9D32DA-3E64-45CD-86CD-ED150EB5B218Q48318960-60F54A6F-8025-43FB-A07D-942CC136DEA0Q48337165-FE47A37D-DA37-4362-BF0C-1F8E7BC7A5E6Q49553301-505EC28D-C1F1-41E6-849D-A144EF3849B7Q49713702-44C62818-B6B6-4A2D-B418-821C3618A5F1Q49713732-7671F702-9E44-4102-BA74-8B28CADAF771Q49903743-B1900751-8DB7-40BE-B71B-381724EA2F81Q50049397-48CE2485-165C-4893-AC05-851954461875Q50776173-E95F0500-E290-48F6-A25D-6ACC978BC77DQ51072120-8758A030-B71B-443D-9D05-EA16F4C04D4EQ52647071-1926AB7E-36D2-44A2-BA20-889AC19EFBCDQ53075897-AD2EB803-FF55-48A6-A5DA-DAC0B732B11DQ53078257-FF4DBE5D-A8C5-4675-B21A-E6441EA9A630Q53119521-A4E6980D-E34A-4EEF-96A9-941526401E2CQ54213485-A0D53ABD-E157-4F35-8026-BA55E2D6F3AAQ57225788-8CE849A5-B9E7-4D7D-9FBD-179F99D99903Q57459902-5573583D-6A0E-4329-BA29-63826F57E623Q57475361-E87E501C-EA67-4149-922A-111EB2A390BBQ58797488-E7A4F5D6-E9CA-4E7D-8AD5-7A6D86AB0AB3Q60957664-32C20354-6BA5-4444-915F-D61EC1897001Q64101506-44A25052-D60E-49D1-A8D6-7913A7A9A765Q64980484-9ACD69A4-16BE-42F2-9067-C902AF3DDCE2Q89700118-98695EBB-42BA-4225-8DEB-919691AB7400Q90268742-1C8DD73D-85D2-4971-8EA9-B1A4B1B2F524Q90309827-AD643B0E-9D4C-4D8E-8FE6-73DE6C92946B
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Sang-Won Lee
@en
Sang-Won Lee
@nl
type
label
Sang-Won Lee
@en
Sang-Won Lee
@nl
prefLabel
Sang-Won Lee
@en
Sang-Won Lee
@nl
P31
P496
0000-0002-8038-3341